Current Opinion in Virology

Papers
(The median citation count of Current Opinion in Virology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial Board187
Mutational escape from cellular immunity in viral hepatitis: variations on a theme146
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2116
Hepatitis-B virus: replication cycle, targets, and antiviral approaches91
The enigmatic roles of Anelloviridae and Redondoviridae in humans91
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?77
Transmission patterns of hepatitis E virus75
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-1969
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy68
Inhaled aerosol viral-vectored vaccines against tuberculosis68
Editorial Board63
Editorial overview: Viral pathogenesis56
Human placental models for studying viral infections52
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs50
Structural basis for neutralization of enterovirus49
Virus–host protein interactions as footprints of human cytomegalovirus replication47
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids46
Editorial Board44
Recent progress in development of monoclonal antibodies against human cytomegalovirus43
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-242
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity40
New preventive strategies for respiratory syncytial virus infection in children40
Emerging technologies in the study of the virome39
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 139
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation37
The journey of herpesvirus capsids and genomes to the host cell nucleus35
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection35
Shopping for phages? Unpacking design rules for therapeutic phage cocktails35
Platelets in the pathogenesis of flavivirus disease32
A complex immune communication between eicosanoids and pulmonary macrophages32
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?32
A review of broadly protective monoclonal antibodies to treat Ebola virus disease31
Mitigation of evolved bacterial resistance to phage therapy30
Perspective on taxonomic classification of uncultivated viruses29
Engineering therapeutic phages for enhanced antibacterial efficacy28
Epigenetic control of the Epstein-Barr lifecycle28
Asymmetry in icosahedral viruses27
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities27
When good turns bad: how viruses exploit innate immunity factors27
Editorial Board27
Hemagglutinin stability as a key determinant of influenza A virus transmission via air26
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity26
Tissue-resident memory T cells in protective immunity to influenza virus26
Retasking of canonical antiviral factors into proviral effectors26
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?26
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity25
Immune responses to human respiratory coronaviruses infection in mouse models24
Modeling zoonotic and vector-borne viruses24
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy24
Mechanisms of HCV resistance to broadly neutralizing antibodies24
Role of the viral polymerase during adaptation of influenza A viruses to new hosts24
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets24
Oncogenic Animal Herpesviruses23
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications23
The virome of vector mosquitoes23
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases22
Deimmunization of flagellin adjuvant for clinical application22
Diagnosis and monitoring of virus-associated cancer using cell-free DNA22
Antigenic evolution of SARS coronavirus 221
The impact of high-resolution structural data on stemming the COVID-19 pandemic21
Bat virome research: the past, the present and the future21
Advances in human monoclonal antibody therapy for HBV infection21
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance20
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?20
Viral Z-RNA triggers ZBP1-dependent cell death20
Broadly neutralizing antibodies against COVID-1920
Editorial overview20
Editorial Board19
Editorial Board19
Mapping conformational epitopes by NMR spectroscopy18
Editorial overview: Viral immunology before COVID-1917
Structure and physiology of giant DNA viruses17
Early signaling pathways in virus-infected cells17
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-217
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells16
Accumulation of host cell genetic errors following high-risk HPV infection16
Microbiota as a potentially-modifiable factor influencing COVID-1916
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales16
Editorial overview: Special issue on phage therapy16
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses15
Structural insights into hepatitis C virus neutralization15
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response15
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers15
Editorial overview: Engineering elimination of chronic viral hepatitis15
How and why RNA genomes are (partially) ordered in viral capsids15
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success15
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-1914
The intestinal virome: lessons from animal models14
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma14
The influence of microbiota-derived metabolites on viral infections14
Editorial overview: Special issue on virus structure and expression in current opinion in virology14
Natural killer cells and unconventional T cells in COVID-1914
Proteases and variants: context matters for SARS-CoV-2 entry assays14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification14
Editorial overview: Virus structure and expression14
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses14
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination13
Editorial Board13
European regulatory aspects of phage therapy: magistral phage preparations13
Editorial Board13
Koala retrovirus and neoplasia: correlation and underlying mechanisms13
Broad neutralizing antibody-based strategies to tackle influenza13
Cryo-EM to visualize the structural organization of viruses13
Editorial Board13
Lying low-chromatin insulation in persistent DNA virus infection13
Phage therapy for secondary bacterial infections with COVID-1913
Editorial Board12
The role of human lipoproteins for hepatitis C virus persistence12
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts12
Therapeutic approaches to Epstein–Barr virus cancers12
A comparative review of adenovirus A12 and C5 oncogenes11
Virus structure and structure-based antivirals11
Endocytosis of Bacteriophages11
Editorial Board11
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology11
Animal models of SARS-CoV-2 transmission11
Zoonotic disease and virome diversity in bats11
Ex vivo culture models to study viral infections of the liver11
An overview of the current state of phage therapy for the treatment of biofilm-related infections11
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing11
The long and winding road: human papillomavirus entry and subcellular trafficking11
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease11
Editorial Board11
0.081614971160889